Provided by Tiger Fintech (Singapore) Pte. Ltd.

Phathom Pharmaceuticals

8.35
-0.1900-2.22%
Post-market: 8.31-0.0400-0.48%18:47 EDT
Volume:501.93K
Turnover:4.20M
Market Cap:581.56M
PE:-1.61
High:8.50
Open:8.40
Low:8.18
Close:8.54
Loading ...

Phathom Pharmaceuticals to Report Second Quarter 2025 Financial Results and Provide Business Update on Thursday, August 7, 2025

GlobeNewswire
·
28 Jul

Phathom Pharmaceuticals Insider Makes Notable Stock Sale

TIPRANKS
·
19 Jul

Phathom Pharmaceuticals' Principal Accounting Officer, Robert Charles Breedlove, Reports Disposal of Common Shares

Reuters
·
19 Jul

Avidity, Phathom mentioned as potential takeout targets at Needham

TIPRANKS
·
18 Jul

Phathom Pharmaceuticals Files Initial Beneficial Ownership Statement for Anne Marie Cook, Chief Legal Officer & Corporate Secretary

Reuters
·
25 Jun

BRIEF-Phathom Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

Reuters
·
24 Jun

Phathom Pharmaceuticals Appoints Anne Marie Cook as Chief Legal Officer and Corporate Secretary

Reuters
·
23 Jun

Phathom Pharmaceuticals Secures 10-Year Regulatory Exclusivity for VOQUEZNA® Tablets Following FDA Correction

Reuters
·
16 Jun

Phathom Pharmaceuticals Inc. Concluded Its Annual Stockholders Meeting

Reuters
·
10 Jun

Phathom Pharmaceuticals price target raised to $17 from $12 at Craig-Hallum

TIPRANKS
·
09 Jun

Phathom Pharmaceuticals Price Target Maintained With a $20.00/Share by HC Wainwright & Co.

Dow Jones
·
09 Jun

Phathom Pharmaceuticals Gains FDA Approval for VOQUEZNA® Exclusivity

TIPRANKS
·
07 Jun

Phathom Pharmaceuticals Gains Momentum with FDA Approval and Market Exclusivity for Voquezna

TIPRANKS
·
07 Jun

Phathom Pharmaceuticals Is Maintained at Buy by Needham

Dow Jones
·
07 Jun

Needham sees FDA’s positive CP ruling as best-case outcome for Phathom

TIPRANKS
·
07 Jun

BUZZ-U.S. STOCKS ON THE MOVE-WEC Energy, FuelCell Energy, Phathom Pharma

Reuters
·
07 Jun

Top Midday Gainers

MT Newswires Live
·
07 Jun

Phathom Pharmaceuticals price target raised to $29 from $23 at Cantor Fitzgerald

TIPRANKS
·
07 Jun

BUZZ-Phathom Pharma soars after FDA grants 10-year exclusivity shield for stomach drug

Reuters
·
07 Jun

Phathom says FDA to correct Orange Book for Voquenza exclusivity

TIPRANKS
·
07 Jun